Anticancer agent 42 (compound 10d) is an orally active, potent anticancer agent with an IC50 of 0.07 µM against MDA-MB-231 cells. It exerts anticancer activity by activating apoptotic pathways and p53 expression. Anticancer agent 42 is a valuable tool for investigating metastatic breast cancer [1].